34523-76-7

Basic information

• Product Name: 3,5-diMethoxy-4-Methyl-Benzoyl chloride
• Synonyms: 3,5-diMethoxy-4-Methyl-Benzoyl chloride
• CAS NO: 34523-76-7
• Molecular Formula: C₁₀H₁₁ClO₃
• Molecular Weight: 214.64554
• Mol File: 34523-76-7.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3,5-diMethoxy-4-Methyl-Benzoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-diMethoxy-4-Methyl-Benzoyl chloride(34523-76-7)
• EPA Substance Registry System: 3,5-diMethoxy-4-Methyl-Benzoyl chloride(34523-76-7)

Safety Data

• Hazardous Substances Data: 34523-76-7(Hazardous Substances Data)

Usage

General Description

3,5-diMethoxy-4-Methyl-Benzoyl chloride is a chemical compound with the molecular formula C10H11ClO3. It is a benzoyl chloride derivative with methoxy and methyl groups attached to the benzene ring. 3,5-diMethoxy-4-Methyl-Benzoyl chloride is used as a building block in organic synthesis, particularly in the production of pharmaceuticals and agrochemicals. It is a versatile reagent that is commonly used in the synthesis of various organic compounds, including dyes, pigments, and polymers. Additionally, 3,5-diMethoxy-4-Methyl-Benzoyl chloride is known for its potential use in the development of new materials and as a reagent in chemical research and development. However, it should be handled with care as it is a corrosive and potentially hazardous chemical.

Upstream product

• 28026-96-2 3,5-dihydroxy-4-methylbenzoic acid 
• 61040-81-1 4-methyl-3,5-dimethoxybenzoic acid 

Downstream Products

• 1130128-07-2 1,3-dihydroxy-2-methyl-5-nonadecylbenzene 
• 1282549-79-4 ethyl 2-{[(3,5-dimethoxy-4-methylbenzoyl)(3-phenylpropyl)amino]methyl}-1,3-thiazole-4-carboxylate 
• 1278597-48-0 C₁₁H₁₁NO₃S 
• 1278597-50-4 C₁₇H₁₉N₃O₅S₂ 
• 1206885-21-3 N-[1-(1,3-benzothiazol-2-ylmethyl)-4-piperidinyl]-4-methyl-3,5-bis(methyloxy)benzamide 
• 1206885-48-4 1,1-dimethylethyl 4-({[4-methyl-3,5-bis(methyloxy)phenyl]carbonyl}amino)-1-piperidinecarboxylate 
• 1093131-23-7 (R)-3,5-dimethoxyl-4-methylbenzoic acid N-(1-tert-butylbutyl)-N'-(3-methoxy-2-methylbenzoyl)hydrazide 
• 1224301-12-5 N,3,5-trimethoxy-N,4-dimethylbenzamide 
• 63037-49-0 3,5-Dimethoxy-4-methyl-phenylethylamin 
• 91247-52-8 <3,5-Dimethoxy-4-methyl-phenyl>-acetamid 
• 724771-83-9 3-(3,5-dimethoxy-4-methyl-phenyl)-3-oxo-propionic acid ethyl ester 
• 91012-99-6 3,5-dimethoxy-4-methyl-benzoic acid amide 
• 676541-52-9 2-[(2-hydroxy-ethylamino)-methyl]-N,N-diisopropyl-3,5-dimethoxy-4-methyl-benzamide 
• 676541-51-8 2-formyl-N,N-diisopropyl-3,5-dimethoxy-4-methylbenzamide 

Relevant articles and documents

Comprehensive Characterisation of n-Alkylresorcinols and Other Lipid Constituents of Mercurialis tomentosa L. from Alicante, Spain

Mercurialis tomentosa L. has been used in Spanish ethnomedicine. In the present study the first phytochemical characterisation of a lipid fraction from M.?tomentosa was performed. The CHCl3 extraction of aerial parts from M.?tomentosa and GC/MS

Total synthesis of chlorofusin, its seven chromophore diastereomers, and key partial structures

Chlorofusin is a recently isolated, naturally occurring inhibitor of p53-MDM2 complex formation whose structure is composed of a densely functionalized azaphilone-derived chromophore linked through the terminal amine of ornithine to a nine residue cyclic peptide. Herein we report the full details of the total synthesis of chlorofusin, resulting in the assignment of the absolute stereochemistry and reassignment of the relative stereochemistry of the complex chromophore. Condensation of each enantiomer of an azaphilone chromophore precursor with the Nδ-amine of a protected ornithine-threonine dipeptide, followed by a one-step oxidation/spirocyclization of the most reactive olefin provided all eight diastereomers of the fully elaborated chromophore-dipeptide conjugate. Comparison of the spectroscopic properties for these eight compounds and those of simpler models with that reported for the natural product allowed the full assignment of the (4R,8S,9R)-stereochemistry of the chlorofusin chromophore. The natural, but stereochemically reassigned, diastereomer of the dipeptide conjugate was incorporated in a convergent total synthesis of chlorofusin confirming the stereochemical reassignment and establishing its absolute stereochemistry. Similarly and enlisting the late stage convergent point in the total synthesis, the remaining seven diastereomers of the chromophore-dipeptide conjugates were individually incorporated into the nine-residue cyclic peptide of chlorofusin (4 steps each) providing all seven remaining possible chromophore diastereomers of the natural product.

COMPOUNDS HAVING LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISM AND USES THEREOF

The present invention relates to a compound represented by formula (I): (wherein the symbols in formula were described in the description), a salt thereof, a solvate thereof or a prodrug thereof. Since the compound of the present invention binds to and is antagonistic to an LPA receptor (particularly, EDG-2), it is useful for prevention and/or treatment of urinary system disease (prostatic hypertrophy or neurogenic bladder dysfunction disease, spinal cord neoplasm, nucleous hernia, spinal canal stenosis, diseases caused by diabetes, occlusion disease of lower urinary tract, inflammatory disease of lower urinary tract, and polyuria), carcinoma-associated disease, proliferative disease, inflammation system disease, immune system disease, disease by secretory dysfunction, brain-related disease and/or chronic disease.